Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H16N4O |
Molecular Weight | 268.3137 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1N=C(C)C2=C1C(=NCC(=O)N2)C3=CC=CC=C3
InChI
InChIKey=YFHYNLHGFKXAIQ-UHFFFAOYSA-N
InChI=1S/C15H16N4O/c1-3-19-15-13(10(2)18-19)17-12(20)9-16-14(15)11-7-5-4-6-8-11/h4-8H,3,9H2,1-2H3,(H,17,20)
Molecular Formula | C15H16N4O |
Molecular Weight | 268.3137 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Ripazepam (CI 683 or pyrazapon) is a pyrazolodiazepine that has anxiolytic effects. It is related to certain benzodiazepines such as zolazepam. In animal studies, it showed anxiolytic effects without sedative or depressant effects. In rats, it did not elicit a tumorigenic potential. Although ripazepam was found significantly superior to placebo and was well tolerated in neurotic patients, it has never been marketed for clinical use.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:20 GMT 2023
by
admin
on
Fri Dec 15 15:20:20 GMT 2023
|
Record UNII |
92000WH9C9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB10328MIG
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
3751
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL159298
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
C009116
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
RIPAZEPAM
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
100000080569
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
C98140
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
92000WH9C9
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
DTXSID1021245
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
26308-28-1
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
2386
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY | |||
|
33474
Created by
admin on Fri Dec 15 15:20:20 GMT 2023 , Edited by admin on Fri Dec 15 15:20:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |